Short Reads | GenomeWeb

Short Reads

Premium

The Presidential Commission for the Study of Bioethical Issues recommended that federal agencies oversee some areas of synthetic biology — including regulation, product licensing, and funding — in order to protect the public from potential risks and to keep research efforts from being stifled.

Fox Chase Cancer Center aims to raise $30 million during the next six years for its new Cancer Genome Institute, which will be dedicated to cancer genome sequencing. Fox Chase is working with Navigenics' Dietrich Stephan to create the center.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.